Skip to main content
. 2018 Jun 25;53(2):117–122. doi: 10.5045/br.2018.53.2.117

Table 3. Literature review on rituximab plus alkylating regimens.

graphic file with name br-53-117-i003.jpg

Abbreviations: DRC, dexamethasone, rituximab, and cyclophosphamide; FN, febrile neutropenia; G, grade; M, median; NA, not applicable; ORR, overall response rate; PFS, progression-free survival; PN, peripheral neuropathy; R-CHOP, rituximab, cyclophosphamide, hydroxy-doxorubicin, vincristine, and prednisone; Ref No., reference number; TTF, time to treatment failure; TTP, time to progression.